産後出血治療機器市場：製品、使用性、流通チャネル、用途別-2025-2030年の世界予測

産後出血治療機器市場は、2023年に8億1,289万米ドルと評価され、2024年には8億6,094万米ドルに達すると予測され、CAGR 6.25％で成長し、2030年には12億4,295万米ドルに達すると予測されています。

分娩後出血（PPH）治療機器は、出産後の過剰な出血を管理・制御するために設計された不可欠な医療ツールであり、世界的に妊産婦死亡の主な原因となっています。これらの医療機器の必要性は、迅速かつ効果的な介入を提供することで、妊産婦の安全を確保し、死亡率を低下させる必要性から生じています。バルーン式タンポナーデ、非空圧式抗ショック衣服、高度血液凝固剤などを含むこれらの機器は、主に病院や産科クリニックなどのヘルスケア施設で採用されています。これらの機器の最終用途には、主に産科医、婦人科医、その他の妊産婦ケアの専門家が関与し、妊産婦ヘルスケア基準の最適化に注力しています。

この市場の主な成長要因は、医療機器の技術進歩とともに、先進地域と新興国の両方で妊産婦の健康に対する意識が高まり、重視されるようになっていることです。さらに、ヘルスケア支出の増加や、妊産婦ケアを改善するための政府のイニシアティブによる支援も、市場拡大に寄与しています。潜在的なビジネスチャンスとしては、費用対効果が高く携帯可能な機器の開発があり、特に資源が限られた環境では極めて重要です。また、企業はデジタル技術を機器の使用に関するトレーニングや教育に活用することで、ヘルスケア従事者の採用率を高めることができます。

市場成長を制限する課題としては、先進的な機器の高価格、低所得地域での限られたアクセス、こうした機器の使い方を訓練された熟練した医療従事者の不足などが挙げられます。また、規制上のハードルも、新規参入企業やイノベーションにとって大きな障壁となっています。これらの制約を克服するために、イノベーションは、使いやすさとモニタリングのしやすさを実現するスマート技術を統合した、経済的に実行可能でユーザーフレンドリーな機器の開発に焦点を当てることができると思われます。さらに研究を進めれば、産科ケアの多面的な側面に対応する多機能機器の開発も検討できると思われます。市場は依然として活況を呈しており、数多くの企業が機器の効率性と安全性を高めるために研究開発に投資しています。利害関係者は、世界な流通網とトレーニングプログラムを育成し、PPH治療機器の普及と受容を確実にするための戦略的協力に注力すべきです。

市場力学：急速に進化する産後出血治療機器市場の主要市場インサイトを公開

産後出血治療機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 逆子宮や多胎妊娠などの妊娠合併症の増加
  • 産後出血の高い有病率
  • 継続的なヘルスケア改革と妊産婦医療サービスの向上を目指した取り組み
• 市場抑制要因
  • 産後出血治療機器の高コスト
• 市場機会
  • 技術の進歩と新しいPPH治療機器の発売
  • 分娩後出血に対する真空誘発性出血抑制装置の出現など
• 市場の課題
  • 訓練を受けたヘルスケアプロバイダーの不足

ポーターの5つの力：産後出血治療機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：産後出血治療機器市場における外部からの影響の把握

外部マクロ環境要因は、産後出血治療機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析産後出血治療機器市場における競合情勢の把握

産後出血治療機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス産後出血治療機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、産後出血治療機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨産後出血治療機器市場における成功への道筋を描く

産後出血治療機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 子宮内反や多胎妊娠などの妊娠合併症の増加
    • 産後出血の有病率が高い
    • 母子保健サービスの改善を目指した継続的なヘルスケア改革と取り組み
  • 抑制要因
    • 産後出血治療機器のコストが高い
  • 機会
    • 技術の進歩と新しいPPH治療機器の発売
    • 産後出血等に対する吸引式出血抑制装置の登場
  • 課題
    • 訓練を受けたヘルスケア従事者の不足
• 市場セグメンテーション分析
  • 製品：即時かつ一時的な対策として非空気圧式耐衝撃衣類を使用することで得られる大きなメリット
  • 流通チャネル：製品を素早く入手できるオフライン流通チャネルを優先
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 産後出血治療機器市場：製品別

• 非空気圧式耐衝撃衣類
• プレフィルド注入システム
• 子宮タンポナーデ器具
  • バルーンタンポナーデ
  • フォーリーカテーテル

第7章 産後出血治療機器市場：ユーザビリティ別

• 使い捨てデバイス
• 再利用可能なデバイス

第8章 産後出血治療機器市場：流通チャネル別

• オフライン
• オンライン

第9章 産後出血治療機器市場：用途別

• クリニック
• 病院

第10章 南北アメリカの産後出血治療機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の産後出血治療機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの産後出血治療機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Laborie Medical Technologies Corp.がUrotronic, Inc.を買収し、介入泌尿器科ポートフォリオを強化
  • MedtradeとKebomed Europe AGが協力し、欧州全域で産後出血ケアを強化
• 戦略分析と提言

企業一覧

• 3RD Stone Design, Inc.
• Bactiguard Holding AB
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Cook Medical, Inc.
• GE HealthCare Technologies, Inc.
• Laborie Medical Technologies, Inc.
• Merck & Co., Inc.
• Organon & Co.
• Procurenet Limited
• Ribbel International Limited
• Sinapi Biomedical
• Teleflex, Inc.
• Utah Medical Products Inc.

LIST OF FIGURES

• FIGURE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFILLED INJECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BALLOON TAMPONADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY FOLEY CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 69. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 74. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 160. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 180. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 185. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 233. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Postpartum Hemorrhage Treatment Devices Market was valued at USD 812.89 million in 2023, expected to reach USD 860.94 million in 2024, and is projected to grow at a CAGR of 6.25%, to USD 1,242.95 million by 2030.

Postpartum hemorrhage (PPH) treatment devices are essential medical tools designed to manage and control excessive bleeding following childbirth, a leading cause of maternal mortality globally. The necessity for these devices stems from the need to ensure maternal safety and reduce mortality rates by providing rapid and effective interventions. These devices, which include balloon tamponade, non-pneumatic anti-shock garments, and advanced blood clotting agents, are employed primarily in healthcare facilities such as hospitals and maternity clinics. The end-use of these devices predominantly involves obstetricians, gynecologists, and other maternity care professionals focused on optimizing maternal healthcare standards.

A key growth factor in this market is the increasing awareness and emphasis on maternal health in both developed and developing regions, alongside technological advancements in medical devices. Additionally, a rise in healthcare expenditures and support from government initiatives to improve maternal care contribute to market expansion. Potential opportunities include the development of cost-effective and portable devices, particularly crucial for resource-limited settings. Companies can also leverage digital technology for training and education on device usage, enhancing adoption rates among healthcare workers.

Challenges limiting market growth include the high cost of advanced devices, limited access in low-income regions, and a deficit of skilled healthcare professionals trained in the usage of such equipment. Regulatory hurdles also pose a significant barrier to entry for new players and innovations. To overcome these limitations, innovation could focus on creating economically viable, user-friendly devices that integrate smart technology for ease of use and monitoring. Further research could explore the development of multifunctional devices that address multiple aspects of obstetric care. The market remains dynamic, with numerous players investing in R&D to enhance device efficiency and safety. Stakeholders should focus on strategic collaborations to foster global distribution networks and training programs, ensuring the widespread implementation and acceptance of PPH treatment devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
  • High prevalence of postpartum hemorrhage
  • Ongoing healthcare reforms and initiatives aimed at improving maternal health services
• Market Restraints
  • High cost of postpartum hemorrhage treatment devices
• Market Opportunities
  • Technological advancements and launch of new PPH treatment devices
  • Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
• Market Challenges
  • Scarcity of trained healthcare providers

Porter's Five Forces: A Strategic Tool for Navigating the Postpartum Hemorrhage Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postpartum Hemorrhage Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postpartum Hemorrhage Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postpartum Hemorrhage Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postpartum Hemorrhage Treatment Devices Market

A detailed market share analysis in the Postpartum Hemorrhage Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postpartum Hemorrhage Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postpartum Hemorrhage Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postpartum Hemorrhage Treatment Devices Market

A strategic analysis of the Postpartum Hemorrhage Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Hemorrhage Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3RD Stone Design, Inc., Bactiguard Holding AB, Becton, Dickinson and Company, Cardinal Health, Inc., Cook Medical, Inc., GE HealthCare Technologies, Inc., Laborie Medical Technologies, Inc., Merck & Co., Inc., Organon & Co., Procurenet Limited, Ribbel International Limited, Sinapi Biomedical, Teleflex, Inc., and Utah Medical Products Inc..

Market Segmentation & Coverage

This research report categorizes the Postpartum Hemorrhage Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, and Uterine Tamponade Devices. The Uterine Tamponade Devices is further studied across Balloon Tamponade and Foley Catheter.
• Based on Usability, market is studied across Disposable Devices and Reusable Devices.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Application, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
    • 5.1.1.2. High prevalence of postpartum hemorrhage
    • 5.1.1.3. Ongoing healthcare reforms and initiatives aimed at improving maternal health services
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of postpartum hemorrhage treatment devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and launch of new PPH treatment devices
    • 5.1.3.2. Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of trained healthcare providers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significant benefits of non-pneumatic anti-shock garments as an immediate and temporary measure
  • 5.2.2. Distribution Channel: Higher preferences for offline distribution channels for quick product accessibility
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Postpartum Hemorrhage Treatment Devices Market, by Product

• 6.1. Introduction
• 6.2. Non-Pneumatic Anti-Shock Garment
• 6.3. Prefilled Injection System
• 6.4. Uterine Tamponade Devices
  • 6.4.1. Balloon Tamponade
  • 6.4.2. Foley Catheter

7. Postpartum Hemorrhage Treatment Devices Market, by Usability

• 7.1. Introduction
• 7.2. Disposable Devices
• 7.3. Reusable Devices

8. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Postpartum Hemorrhage Treatment Devices Market, by Application

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Hospitals

10. Americas Postpartum Hemorrhage Treatment Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Postpartum Hemorrhage Treatment Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Postpartum Hemorrhage Treatment Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Laborie Medical Technologies Corp. Acquires Urotronic, Inc. to Enhance Interventional Urology Portfolio
  • 13.3.2. Medtrade and Kebomed Europe AG Join Forces to Enhance Postpartum Hemorrhage Care Across Europe
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3RD Stone Design, Inc.
• 2. Bactiguard Holding AB
• 3. Becton, Dickinson and Company
• 4. Cardinal Health, Inc.
• 5. Cook Medical, Inc.
• 6. GE HealthCare Technologies, Inc.
• 7. Laborie Medical Technologies, Inc.
• 8. Merck & Co., Inc.
• 9. Organon & Co.
• 10. Procurenet Limited
• 11. Ribbel International Limited
• 12. Sinapi Biomedical
• 13. Teleflex, Inc.
• 14. Utah Medical Products Inc.